Showing results (41-50 of 143) with videos related to

Sort By:
Pageof 15
Japanese Journal of Clinical Oncology|November 19, 2020
An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' studyAlessandra Mosca, Ugo De Giorgi, Giuseppe Procopio, et al.
Tumori|July 23, 2021
Prognostic role of hematologic parameters of metastatic renal cell carcinoma treated with sunitinibElena Bolzacchini, Monica Giordano, Lorenza Bertù, et al.
Biomedicines|October 27, 2022
Long-Term Response to Tyrosine Kinase Inhibitors for Metastatic Renal Cell CarcinomaMartina Catalano, Ugo De Giorgi, Marco Maruzzo, et al.
International Journal of Behavioral Medicine|December 2, 2022
Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital CancersPinuccia Faviana, Laura Boldrini, Lisa Gronchi, et al.
Clinical Genitourinary Cancer|June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World PopulationGiorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in ItalyElena Verzoni, Giovanni Pappagallo, Filippo Alongi, et al.
European Urology|October 14, 2016
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer PatientsMarzia Del Re, Elisa Biasco, Stefania Crucitta, et al.
Anticancer Research|August 1, 2018
Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian ExperienceAndrea Sbrana, Elisa Biasco, Federico Paolieri, et al.
Anticancer Research|May 31, 2022
Early <i>Versus</i> Late Postoperative Radiotherapy in Patients With Prostate Cancer: Results of a Single-centre Retrospective StudyFrancesco Pasqualetti, Elisa Calistri, Taiusha Fuentes, et al.
Therapeutic Advances in Urology|January 20, 2026
Real-world use of enfortumab vedotin in metastatic urothelial carcinoma: efficacy, safety, and risk stratificationMartina Catalano, Sara Bartoli, Alessia Salfi, et al.
Pageof 15